Page 5 - Goldman Sachs

Weak demand weighs on Asian Paints Q3; analysts see more pain in near-term

Asian Paints' consolidated net profit attributable to the owners of the company declined 23.3 per cent year-on-year (Y-o-Y) to Rs 1,110.5 crore in Q3FY25, down from Rs 1,447.7 crore in Q3FY24

Trump's tariffs to have limited impact on oil, gas prices: Goldman Sachs

Potential tariff-driven decline in US natural gas imports from Canada is too small to significantly raise US natural gas prices, the bank said

President Putin allows Goldman Sachs to sell its business in Russia

Putin permitted Balchug Capital to buy the division, according to a decree he signed

Tata Consumer share up 5% despite muted Q3; tea inflation worries analysts

Analysts observed that Tata Consumer Products faced margin pressures primarily due to inflationary tea prices but continued to post robust volume growth across its beverage and food segments

Tata Motors Q3 disappoints, analysts lower targets, ratings; stock tanks 9%

Tata Motors' consolidated profit for Q3FY25 fell 22.4 per cent year-on-year (Y-o-Y) to Rs 5,451 crore, from Rs 7,025 crore in Q3FY24

Most brokerages lift targets for UltraTech Cement as Q3 nos. top estimates

Goldman Sachs reportedly has maintained a 'Buy' rating and increased its target price to Rs 12,580, up from Rs 12,460, citing volume recovery and lower costs contributing to margin improvement

Goldman boosts CEO pay by 26% to $39 mn, lines up five more years at helm

The latest bonuses are an effort by Goldman's board to retain the CEO and COO as a senior leadership team, the company said in the filing

CCI fines Goldman Sachs manager Rs 40 lakh over Biocon deal failure

The Competition Commission has imposed a penalty of Rs 40 lakh on the investment manager of Goldman Sachs AIF for failing to notify the regulator about the more than four-year-old deal that gives the option to buy up to 3.81 per cent stake in Biocon Biologics. The penalty was levied on Goldman Sachs (India) Alternative Investment Management Pvt Ltd (GS AIMPL), the investment manager of Goldman Sachs AIF, for a contravention of Section 6(2) of the Competition Act, which mandates prior approval for certain combinations. Under the deal, Goldman Sachs AIF Scheme-1 (GS AIF) had acquired optionally convertible debentures (OCDs) issued by Biocon Biologics. The regulator has penalised GS AIMPL for failing to notify the transaction to it and rejected the argument that the deal was done in the ordinary course of business. "Any transaction which is made with the intent of remaining invested for a relatively longer period and involves the acquisition of any additional rights (compared to the .

Goldman Sachs profit surges as investment banking, trading fuel Q4 growth

Profit rose to $4.11 billion, or $11.95 per diluted share, for the three months ended Dec. 31, compared with $2.01 billion, or $5.48 per diluted share, a year ago

Budget FY26: Goldman Sachs highlights focus on fiscal deficit, growth

India's elevated public debt-to-GDP ratio remains a concern. A reduction in the general fiscal deficit from 8 per cent in FY25 to 7 per cent by FY30 is critical to keeping public debt sustainable

Aragen secures $100 mn funding from Quadria Capital, plans expansion

Contract research, development and manufacturing organisation Aragen on Monday said it has secured USD 100 million investment from private equity fund Quadria Capital. The investment will result in Quadria acquiring a minority stake in Aragen, at a valuation of around USD 1.4 billion, primarily through a fresh capital infusion, with a small portion from the sale of shares by existing investors, the company said in a statement. The funding will support the company's strategic expansion of its capabilities and infrastructure, enabling it to meet the growing demand for outsourcing services from innovators in the US and Europe, it added. With investment, Quadria joins Goldman Sachs as the second strategic investor in Aragen. "This investment marks a pivotal moment as we scale to meet the needs of a rapidly evolving market, said Manni Kantipudi, CEO, Aragen Life Science. "Our expanded capabilities will allow us to support the rising demand for integrated discovery and manufacturing ...

Goldman Sachs initiates coverage with 'Neutral' on BSE; share price up 2%

The uptick in the BSE share price came after New York, US-based brokerage Goldman Sachs initiated coverage with 'Neutral' rating for a target price of Rs 5,060

Here's why foreign brokerages see up to 36% upside in RIL; Q3 nos on Jan 16

Goldman Sachs, Bernstein, CLSA and Jefferies have retained their positive rating on RIL and believe the selling in the stock is overdone at present levels.

NestAway co-founder accuses Tiger Global, Chiratae, Goldman Sachs of fraud

Sahu's complaint alleges that his signature as a company director was illegally used to finalise NestAway's Rs 90-crore sale to proptech firm Aurum on June 28, 2023

Goldman Sachs eyes majority stake in Multiples PE-backed PeopleStrong

The deal is expected to value Gurugram-based HR tech firm PeopleStrong at approximately Rs 1,500 crore

Goldman Sachs sees Nifty at 27K in 2025, bets on housing, defence stocks

Analysts identified 16 'oversold' stocks, each down over 20%, including Trent, IndiGo, Shriram Finance, and Havells, suggesting they present strong buying opportunities

Gold prices up 30% in 2024; set for best calendar year show in 10 yrs: WGC

Goldman Sachs expects gold prices to reach $3,150 per ounce (bull-case scenario; base case: $3,000/oz) by December 2025, an upside of around 17 per cent from the current levels

Bhartia family to acquire 40% stake in Hindustan Coca-Cola for Rs 12,500 cr

The Jubilant Group's Bhartia family is investing Rs 5,000 crore and the remaining amount is being financed by Goldman Sachs, which has pledged to fund a special purpose vehicle for the deal

A $500 billion haul reignites passive controversy on Wall Street

Contrary to popular claims that price-agnostic money is fuelling market distortions by blithely lavishing capital just to largest companies, a Goldman Sachs Group study showed the role of fundamentals

Goldman Sachs quits climate coalition for banks, biggest one to exit group

Goldman Sachs gave no explicit reason for its departure, but focused on its strategy for the future and a growing push by regulators to make sustainability efforts mandatory